Aaron Gerds, MD from Cleveland Clinics discusses Glasdegib intended to be long-term goal for treating myelofibrosis and isolating the roots of the disease is a focus in the field going forward at the 2017 American Society of Hematology.
Glasdegib Intended to be Long-Term Goal for Treating Myelofibrosis – Isolating the roots of the disease is a focus in the field going forward
